Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.moneycontrol.com/news/trends/health/study-links-bharat-biotechs-rotovac-to-increased-risk-of-bowel-issues-in-infants-company-defends-safety-report-12749695.html
0
0
Study links Bharat Biotech's Rotovac to increased risk of bowel issues in infants; company defends safety:... - Moneycontrol
+ 138 more
6/15/24 at 10:15pm
Organization
Moneycontrol
Author
Moneycontrol News
Details
49 words
Summarize
Public Safety
general
Public Health
Infectious Diseases
Medical Facilities & Services
Bharat Biotech
Rotovac
Moneycontrol Bharat Biotech
India
International Journal of Risk
Bharat Biotech's Rotovac vaccine, part of India's immunisation drive, linked to higher infant intussusception risk in a study published in the International Journal of Risk and Safety in Medicine.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...